McKesson planned to acquire Spectrum Vision Partners from Blue Sea Capital, according to a report in late August cited by a healthcare deal newsletter. The deal stage is announced; the sources do not state that the transaction has closed.
The purchase price was not disclosed in the sources.
The source describes the move as part of a broader pattern of drug distributors buying up specialty practices. It lists other transactions in that pattern: Cencora's announced definitive agreement to acquire American Oncology Network and its network of 350 oncology providers across 21 states, at an enterprise value of up to $2.4 billion; Cencora's earlier completed acquisition of OneOncology from TPG for $5 billion; McKesson's acquisition last year of 70% of Florida Cancer Specialists & Research Institute's MSO Core Ventures for $2.49 billion; and Cardinal Health's 2024 acquisition of Integrated Oncology Network for $1.115 billion.
The same source notes that McKesson has since agreed to acquire 49% of Option Care Health.